Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Topics in Pharmacology   Volumes    Volume 5 
The neuropharmacology of the endogenous cannabinoid transmission: potential therapeutic applications
Miguel Navarro, Raquel Gómez, Ainhoa Bilbao, Miguel Angel Gorriti, Jose Luis Martín-Calderón, Ignacio del Arco, Fernando Rodríguez De Fonseca
Pages: 19 - 29
Number of pages: 11
Current Topics in Pharmacology
Volume 5 

Copyright © 2000 Research Trends. All rights reserved


The potential utility of drugs modulating the endogenous cannabinoid signaling system is reviewed in the present work. The discovery in 1988 of a brain cannabinoid receptor (CB1) and the isolation in 1992 of the first endogenous ligand for that receptor, anandamide, demonstrated the existence in the brain of an endogenous cannabinoid signaling system. The recent development of new drugs such as those aimed to interact with either the CB1 or the mechanisms involved on the release, uptake and degradation of endogenous cannabinoids will help to develop new strategies for the treatment of psychiatric and neurological disorders. They include the psychosis, addiction, motor disorders such as Parkinson`s disease and choreas, epilepsy, pain, appetite and memory. The old social claim of using marijuana as a medicine has now become a very active scientific field of research thanks to the recent advances in the neuropharmacology of the endogenous cannabinoid system.

Buy this Article


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms